Regular monitoring through blood testing helps optimize injection frequency, ensuring you maintain therapeutic B12 levels without over-supplementation
NICE obesity guidance (CG189) recommends multicomponent interventions addressing diet, physical activity, and behaviour change as first-line management
the result is hepatocyte injury and death, which perpetuates inflammation and fibrosis Genetic variants and risk of NAFLD Increased risk of NAFLD: variants in PNPLA3, TM6FSF2, and MBOAT7 Decreased risk of NAFLD: variants in HSD17B13 Histologic features of NASH are assessed with the NAFLD activity score, which includes severity of steatosis, lobular inflammation, and hepatocyte ballooning Clinical Manifestations The clinical, laboratory, histologic, and diagnostic features of NAFLD are listed in Table 34.3
doi: 10.4149/gpb_2009_02_105 [DOI] [PubMed] [Google Scholar] 52.Jenssen H, Hamill P, Hancock REW